(PharmaNewsWire.Com, November 02, 2017 ) Browse 88 Market Data Tables and 33 Figures spread through 140 Pages and in-depth TOC on "Surgical Drains/Wound Drainage Market"
Early buyers will receive 10% customization on this report.
The accessories segment is expected to dominate the market in 2017
Based on product, the surgical drains market is segmented into accessories and surgical drainage systems. In 2017, the accessories segment is expected to account for the largest share of the surgical drains market.
The large share of this segment is attributed to the frequent use of accessories in a number of surgical procedures and its affordability as compared to surgical drainage systems.
Based on application, the cardiac and thoracic surgery segment is projected to grow at the highest CAGR during the forecast period.
By applications, the surgical drains market is segmented into general surgery, cardiac and thoracic surgery, orthopedic surgery, obstetrics/gynecology surgery, and other surgeries. The cardiac and thoracic surgery segment is expected to grow at the highest rate during the forecast period.
The high growth of this market is attributed to the large number of thoracic & cardiovascular surgeries performed across the globe owing to the high prevalence of cardiovascular diseases (CVDs).
North America to dominate the surgical drains market
In 2017, North America is expected to dominate the market followed by Europe.
The large share of this geographical segment is attributed to factors such as increasing incidence of chronic wounds and surgical site infections, growing number of surgical procedures, rising geriatric population, and higher adoption and awareness of advanced surgical and wound care products.
The surgical drains market is highly competitive with the presence of several small and big players. Some of the players in the surgical drains market include B. Braun (Germany), Cardinal Health (US), ConvaTec (UK), C.R. Bard (US), Redax (Italy), Ethicon (US), Stryker (US), Romsons (India), Medtronic (Ireland), Medline Industries (US), Cook Medical (US), Poly Medicure (India), Zimmer Biomet (Indiana), Global Medikit (India), and Degania Silicone (Israel).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
